Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.66% | $942.52M | €358.11B | 50.10% | 78 Outperform | |
| SAP SE | 1.91% | $675.90M | €263.59B | 6.04% | 73 Outperform | |
| HSBC Holdings | 1.70% | $602.83M | £184.03B | 50.32% | 79 Outperform | |
| Novartis AG | 1.66% | $589.62M | CHF188.19B | 5.42% | 78 Outperform | |
| Roche Holding AG | 1.61% | $571.38M | CHF209.75B | 5.79% | 73 Outperform | |
| Nestlé SA | 1.61% | $570.46M | CHF195.74B | 1.23% | 65 Neutral | |
| AstraZeneca | 1.59% | $563.81M | £194.50B | 13.62% | 75 Outperform | |
| Shell (UK) | 1.45% | $515.16M | £166.03B | 11.81% | 77 Outperform | |
| Siemens | 1.37% | $486.72M | €193.45B | 37.04% | 74 Outperform | |
| ― | 1.23% | $435.66M | ― | ― | ― |